Obalon Therapeutics Inc. (OBLN)
NASDAQ: OBLN
· Real-Time Price · USD
3.05
-0.19 (-5.86%)
At close: Jun 16, 2021, 6:00 AM
Obalon Therapeutics Revenue
Obalon Therapeutics reported an annual revenue of $1.59M, reflecting a -51.6% growth. For the quarter ending June 30, 2021, Obalon Therapeutics generated $3.53K in revenue.
Revenue (ttm)
1.59M
Revenue Growth
-51.6%
Price / Sales Ratio
7.34
Revenue / Employee
794K
Employees
2
Market Cap
5.47M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2020 | 1.59M | -51.60% |
| Dec 31, 2019 | 3.28M | -63.95% |
| Dec 31, 2018 | 9.1M | -8.20% |
| Dec 31, 2017 | 9.91M | +192.19% |
| Dec 31, 2016 | 3.39M | -15.99% |
| Dec 31, 2015 | 4.04M | +14.13% |
| Dec 31, 2014 | 3.54M | n/a |